Goldman Sachs
BNGO icon

Goldman Sachs’s Bionano Genomics BNGO Stock Holding History

Goldman Sachs’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-184
Closed -$3.18K – 6080
2024
Q4 		$3.18K Buy
+184
New +$3.15K ﹤0.01% 5966
2023
Q3 		– Sell
-731
Closed -$268K – 5554
2023
Q2 		$268K Sell
731
-42
-5% -$19K ﹤0.01% 5066
2023
Q1 		$515K Sell
773
-711
-48% -$632K ﹤0.01% 4807
2022
Q4 		$1.3M Sell
1,484
-25
-2% -$31.5K ﹤0.01% 4257
2022
Q3 		$1.66M Buy
1,509
+259
+21% +$342K ﹤0.01% 4124
2022
Q2 		$1.03M Buy
1,250
+213
+21% +$219K ﹤0.01% 4585
2022
Q1 		$1.6M Sell
1,037
-10
-1% -$13.5K ﹤0.01% 4429
2021
Q4 		$1.88M Buy
1,047
+581
+125% +$1.55M ﹤0.01% 4303
2021
Q3 		$1.54M Sell
466
-292
-39% -$1.02M ﹤0.01% 4412
2021
Q2 		$3.33M Buy
758
+424
+127% +$1.67M ﹤0.01% 3718
2021
Q1 		$1.62M Buy
+334
New +$1.88M ﹤0.01% 4190

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Goldman Sachs's BNGO Position: Q1 2025 in Review

Goldman Sachs sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 184 shares — an estimated $3.18K sold.

Goldman Sachs first reported a position in BNGO in Q1 2021 and held it in 11 quarters. The position peaked at $3.33M in Q2 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Goldman Sachs reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • Goldman Sachs sold 184 Bionano Genomics shares in Q1 2025, an estimated $3.18K.
  • Goldman Sachs first reported a position in Bionano Genomics in Q1 2021 and held it in 11 quarters.
  • Goldman Sachs's Bionano Genomics position peaked at $3.33M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.